1st Quarter - Report
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
Income
—
Expenses
$446,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D-activities related to HR 2415/S 1184 (The Treat and Reduce Obesity Act of 2013); Part D Protected classes provision of Affordable Care Act; Part D forumulary requirements-manual; Alzheimer's disease Part D coverage; CMS letter re: quarterly NOC update
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| SHELLEY STEWART | — |
| DEBORAH LYNN WALTER | — |
Trade (domestic/foreign) TRD
H.R. 3204: The Drug Quality and Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.